Skip to content

Effect of Access to Dietary Intervention in a Dialysis Unit

EFFECT Diet - Cluster RCT and Qualitative Inquiry

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06996405
Acronym
EFFECTdiet
Enrollment
40
Registered
2025-05-30
Start date
2024-11-27
Completion date
2026-09-30
Last updated
2025-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Dialysis, Diet Therapy, Nutritional Status

Keywords

Dietary intervention, Dietitian

Brief summary

Objective: The aim of this study is to explore the effect of access to individual dietary counselling by a dietitian in the dialysis unit on biochemical values (phosphorus and potassium), diet, nutritional status, quality of life (QoL) and health literacy (HL). Hypothesis: Having access to a dietitian can better laboratory values and affect dietary intake, nutritional status, QoL and HL in a positive matter. Method: Pilot cluster RCT study in three the dialysis units in Region Zealand. Clustering of people on dialysis the same day to either intervention or control group. The groups is expected to be similar regarding clinical characteristics. Primary outcome: Change in average p-phosphate Secondary outcomes: Change in average p-potassium, number of phosphate binders, number of potassium binders, HeartDiet-score, Nutritional Status, Adherence to diet (End Stage Renal Disease Adherence Questionnaire), Quality of life (Kidney Disease Quality of Life Short Form) and Health literacy (Health Literacy Questionnaire) Intervention: The intervention group receives an initial individual dietary interview, monthly follow-up and weekly access to a dietitian in the dialysis unit for four months. The control group receives usual care with referral to a dietitian when needed.

Detailed description

Objective: The aim of this study is to explore the effect of access to individual dietary counselling by a dietitian in the dialysis unit on biochemical values (phosphorus and potassium), diet, nutritional status, quality of life (QoL) and health literacy (HL). Research question: What is the effect of access to dietary treatment in people receiving dialysis treatment on biochemical values (phosphorus and potassium), diet, nutritional status, quality of life and health literacy? Hypothesis: Having access to a dietitian can better laboratory values and affect dietary intake, nutritional status, QoL and HL in a positive matter. Method: Pilot cluster RCT study in the dialysis units in Holbæk and Slagelse in Region Zealand, Denmark. Clustering of people on dialysis the same day to either intervention or control group. The groups is expected to be similar regarding clinical characteristics. A pilot project will be conducted in 2024 in the dialysis units in Slagelse and Holbæk. Data collection: Both groups: * Patient characteristics (at the beginning of project): Age and gender, height, medical diagnosis, socioeconomic data (income, job, education, partner status) and dialysis vintage. * Clinical Data (before and after the intervention, and at 6 and 12 month after the intervention period): Biochemical values (phosphate, potassium, urea, albumin, PTH), anthropometric measures (dry weight, actual weight), medication, ultrafiltration, and number of contacts with dietitian. * Questionnaires and tests (collected before and after the intervention): Body composition (fat, fat-free mass, water), Nutritional status, Intake (HeartDiet Questionnaire), Quality of Life (KDQOL-SF), Health Literacy (HLQ), and previous dietary treatment. Primary outcome: Change in average p-phosphate Secondary outcomes: Change in average p-potassium, number of phosphate binders, number of potassium binders, HeartDiet-score, Nutritional Status (nutritional screening), Adherence to diet (End Stage Renal Disease Adherence Questionnaire, ESRD-AQ-score), Quality of life (Kidney Disease Quality of Life Short Form, KDQOL-SF-score) and Health literacy (Health Literacy Questionnaire, HLQ-score) Intervention: The intervention group receives an initial individual dietary interview, monthly follow-up and weekly access to a dietitian in the dialysis unit for four months. The individualized dietary treatment based on the patient's preferences and needs according to the Nutrition Care Process. It is carried out according to the practical guidelines from the Danish Dietetic Association on dietary treatment of chronic kidney disease. The dietary treatment uses a dialogic and person-centered approach The intervention is described in the protocol using the TIDieR framework. The control group receives usual care with referral to a dietitian when needed. Statistics: The average phosphorus level and standard deviation after a diet intervention was 1.58 ± 0.32 mmol/l, therefore using 0.32 mmol/l in calculation of sample size. An implementation of guidelines and a systematic review showed a difference in phosphosus levels between intervention and control group of 0.23 and 0.30 mmol/l respectively. Calculation of sample size using Sample Size Calculator (clincalc.com). Using the values mentioned above, a power of 80% and a significance of 5% shows a sample size of 18-30 people in each group to show a significant change in phosphorus levels. Comparison of changes in average values using unpaired t-test, including endpoints of p-phosphorous and p-potassium, QoL-score and health literacy score. For dichotomous endpoints such as nutritional score, comparison of the percentage of the groups within and without specific limits. Data analysis with intention-to-treat and statistical calculations by a person not familiar with the groups.

Interventions

OTHERAccess to dietary treatment

Dietary treatment using current nutrition guidelines, dialogic communication and Nutrition Care Process repeatedly by weekly access to a dietitian for four month.

Sponsors

Steno Diabetes Center Sjaelland
CollaboratorOTHER_GOV
The Danish Kidney Association
CollaboratorOTHER
VIA University College
CollaboratorOTHER
The Danish Dietetic Association
CollaboratorOTHER
Zealand University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Able to understand Danish * Chronic dialysis treatment (min. 3 month)

Exclusion criteria

* Dementia * Not able to sign a consent form * Expected short duration of life, eg. terminal cancer

Design outcomes

Primary

MeasureTime frameDescription
Average phosphateAt baseline and after 5 month at the end of the intervention period (last phosphate value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)Difference in average phosphate-level between groups

Secondary

MeasureTime frameDescription
Phosphate bindersAt baseline, changes within the intervention period, after 5 month at the end of the intervention period, and 6 and 12 month after the last day of the interventionChange in numbers of prescribed phosphate binders
Average potassiumAt baseline and after 5 month at the end of the intervention period (last potassium value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)Difference in average potassium-level between groups
Potassium-levelAt baseline and after 5 month at the end of the intervention period (last potassium value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)Number of patients with potassium-level within range
Potassium bindersAt baseline, changes within the intervention period, after 5 month at the end of the intervention period, and 6 and 12 month after the last day of the interventionChange in numbers of prescribed potassium binders
Nutritional StatusAt baseline and after 5 month at the end of the intervention periodNutritional screening according to Nutritional Risk Screening (NRS-2002)
Phosphate-levelAt baseline and after 5 month at the end of the intervention period (last phosphate value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)Number of patients with phosphate-level within range
Quality of Life-scoreAt baseline and after 5 month at the end of the intervention periodQuality of Life-score using the questionnaire Kidney Disease Quality of Life Short Form (KDQOL-SF)
Adherence-scoreAt baseline and after 5 month at the end of the intervention periodAdherence-score using the questionnaire End Stage Renal Disease Adherence Questionnaire (ESRD-AQ)
Symptom-scoreAt baseline and after 5 month at the end of the intervention periodSymptom-score using the questionnaire The Integrated Palliative Outcome Scale - Renal (IPOS-RENAL)
Health Literacy Questionnaire-scoreAt baseline and after 5 month at the end of the intervention periodHealth Literacy Questionnaire-score using the questionnaire Health Literacy Questionnaire (HLQ)
Nutritional intakeAt baseline and after 5 month at the end of the intervention periodNutritional intake collected using the food frequency questionnaire HeartDiet

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026